Curii Corporation

Cambridge, MA

UEI
PMY9MDD52KN5
CAGE
7UQ21
Primary NAICS
518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1 Broadway, Cambridge, MA 02142, USA
Website
curii.com
Founded
2020
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Information Technology
  2. Software & Services
  3. Internet Software & Services
SIC code
73 Business Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Southern California Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks U01AG068057 $682,950
University Of Southern California Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks U01AG068057 $684,270

Similar vendors

About the company

Curii Corporation, a for-profit entity based in Cambridge, Massachusetts, receives federal research funding as a prime grant recipient focused on developing reference materials and biobanks for cancer diagnostics and precision medicine research. The vendor operates predominantly as a grant recipient rather than a federal contractor — three of five recent awards are prime grants, with two sub-awards from University of Southern California on National Institutes of Health programs.

Curii's federal footprint centers on the National Institutes of Health and the National Institute of Standards and Technology. The top four funding agencies account for 100% of recent awards: the NIH National Institute on Aging (2 awards), the NIST (1 award), the NIH National Human Genome Research Institute (1 award), and the NIH National Institute of General Medical Sciences (1 award). The vendor's primary prime-grant work is a cooperative agreement from NIST awarded October 1, 2021, titled "Development of Matched Tumor and Normal Cell Lines Under Open Consent for Reference Materials That Support Cancer Measurements," with an ultimate completion date of September 30, 2025. Under that grant, Curii works with the Harvard Personal Genome Project to develop cancer reference materials from openly-consented participants, aiming to immortalize human tumor and normal cell lines for use in cancer diagnostic and research laboratories. Curii also serves as a sub-recipient on two related awards under University of Southern California primes — both titled "Ultrascale Machine Learning to Empower Discovery in Alzheimer's Disease Biobanks," awarded in June 2024 and February 2025 — supporting biobank data analysis and discovery research.

Activity remains sparse but consistent: five total awards since 2017, with $4 million combined obligated value. The vendor's recompete exposure is concentrated in the NIST cooperative agreement, which reaches ultimate completion on September 30, 2025, marking the end of that funding cycle.

Quick answers

Is Curii Corporation registered in SAM.gov?

Yes. Curii Corporation's SAM.gov registration is active through April 7, 2027.

What is Curii Corporation's most recent federal award?

Curii Corporation's most recent federal grant award is Development of matched tumor and normal cell lines under open consent for reference materials that support cancer… (70NANB21H139), from National Institute of Standards and Technology, on October 1, 2021.

On GovTribe

See Curii Corporation's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors